Medicina alternativa e integrativa

Traditional Chinese Medicine (TCM) has been used for centuries in China and other parts of Asia for the prevention and treatment of various diseases, including cancer. Recently, interest in TCM has grown in the Western world as a complementary approach in oncology. This review aims to synthesize the current evidence from clinical trials on the efficacy and safety of TCM in cancer treatment, focusing on outcomes such as symptom management, quality of life and survival rates. The review also discusses the integration of TCM with conventional cancer therapies and identifies future research directions.

Anxiety and depression are prevalent mental health conditions that significantly impact quality of life and overall well-being. Conventional treatments, including psychotherapy and pharmacotherapy, are commonly used to manage these disorders. Recently, yoga therapy has emerged as a complementary approach with potential benefits for mental health. This study aims to compare the effects of yoga therapy with conventional treatments on anxiety and depression, evaluating their efficacy, mechanisms and practical implications.

Type 2 diabetes (T2D) represents a significant global health challenge, characterized by insulin resistance and high blood glucose levels. While conventional treatments primarily involve lifestyle modifications and pharmacotherapy, there is increasing interest in integrative approaches that combine traditional and complementary therapies. This article reviews the efficacy of integrating conventional treatments with complementary therapies such as dietary supplements, acupuncture and mind-body practices, exploring their potential benefits and limitations in managing T2D.

Objective: To systematically review the impact of Mindfulness-Based Stress Reduction (MBSR) on quality of life (QoL) among cancer patients.

Methods: A comprehensive search was conducted in databases including PubMed, Cochrane Library and PsycINFO for studies published up to July 2024. Inclusion criteria encompassed randomized controlled trials (RCTs) and quasi-experimental studies evaluating MBSR interventions in adult cancer patients, with QoL as a primary or secondary outcome. Data on study characteristics, participant demographics, intervention details and QoL outcomes were extracted. A meta-analysis was performed to determine the overall effect of MBSR on QoL, with subgroup analyses based on cancer type, stage and MBSR duration.

Results: A total of 20 studies involving 1,200 participants were included. The meta-analysis indicated a moderate effect size for MBSR in improving QoL (Standardized Mean Difference [SMD] = 0.45, 95% Confidence Interval [CI] [0.35, 0.55]). Subgroup analyses showed that MBSR was particularly effective for patients with breast cancer (SMD = 0.50, 95% CI [0.38, 0.62]) and those in the early stages of treatment (SMD = 0.48, 95% CI [0.36, 0.60]). Variability in intervention protocols and outcome measures were noted.

Conclusion: MBSR demonstrates a moderate improvement in QoL for cancer patients, with notable benefits observed in specific cancer types and treatment stages. The findings support the integration of MBSR into cancer care, though further research is needed to optimize program delivery and assess long-term effects.